Skip to main content
Top
Literature
3.
go back to reference Liu M, Degner J, Georgantas RW et al (2020) A genetic variant in the BCL2 Gene Associates with Adalimumab Response in Hidradenitis Suppurativa clinical trials and regulates expression of BCL2. J Invest Dermatol 140:574–582e2CrossRefPubMed Liu M, Degner J, Georgantas RW et al (2020) A genetic variant in the BCL2 Gene Associates with Adalimumab Response in Hidradenitis Suppurativa clinical trials and regulates expression of BCL2. J Invest Dermatol 140:574–582e2CrossRefPubMed
4.
go back to reference Mintoff D, Pace NP, Borg I (2023) Management of patients with hidradenitis suppurativa having underlying genetic variation: a systematic review and a call for precision medicine. Clin Exp Dermatol 48:67–72CrossRefPubMed Mintoff D, Pace NP, Borg I (2023) Management of patients with hidradenitis suppurativa having underlying genetic variation: a systematic review and a call for precision medicine. Clin Exp Dermatol 48:67–72CrossRefPubMed
5.
go back to reference Konda V, Huo D, Hermes G et al (2006) Do patients with inflammatory bowel disease want genetic testing? Inflamm Bowel Dis 12:497–502CrossRefPubMed Konda V, Huo D, Hermes G et al (2006) Do patients with inflammatory bowel disease want genetic testing? Inflamm Bowel Dis 12:497–502CrossRefPubMed
Metadata
Title
Attitudes of patients with hidradenitis suppurativa towards genomic testing: a survey
Authors
Luca Borg
Bettina Booker
Nikolai P Pace
Dillon Mintoff
Publication date
01-11-2024
Publisher
Springer Berlin Heidelberg
Published in
Archives of Dermatological Research / Issue 9/2024
Print ISSN: 0340-3696
Electronic ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-024-03374-6

Other articles of this Issue 9/2024

Archives of Dermatological Research 9/2024 Go to the issue